PMID: 9430196Jul 1, 1997Paper

Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21

Molecular Immunology
H IllgesI Melchers

Abstract

CD21 is found in a soluble form at low levels in normal human sera and at elevated levels in sera from patients with EBV-associated diseases and B-CLL. Ablation of complement, injection of recombinant soluble CD21 and knock-out of CD21 in mice by gene targeting interfere with T-cell-dependent immune responses, suggesting that in vivo-generated soluble CD21 may exert immunoregulatory functions. Soluble CD21 has a molecular weight of 130,000/135,000, which is equivalent to the entire extracellular domain. Soluble forms of membrane-anchored molecules may be generated by proteolytic cleavage of the extracellular portion or by the exclusion of the hydrophobic transmembrane region via alternative splicing. To delineate whether alternative splicing of CD21 mRNA creates transcripts encoding for the soluble form of CD21 we analyzed by PCR CD21 expression in PBLs, spleen, tonsils, bone marrow and in various cell lines. We found that all CD21 mRNA species contained the transmembrane exons, thus excluding alternative splicing as a factor contributing to the serum pool of soluble CD21. Differential splicing of the CD21 transcription unit has also been suggested for exon 11. Within the CD21 gene exons 3, 7 and 11 have a high degree of homolo...Continue Reading

References

Aug 1, 1992·Immunobiology·N R Ling, B Brown
Aug 6, 1992·Nature·J P AubryJ Y Bonnefoy
Aug 1, 1990·The Journal of Experimental Medicine·B HeymanT Kinoshita
Dec 1, 1989·The Journal of Experimental Medicine·C A LowellJ M Ahearn
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M D MooreG R Nemerow
Feb 1, 1986·Lancet·L S YoungA B Rickinson
Aug 1, 1988·European Journal of Immunology·C D Tsoukas, J D Lambris
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J D LambrisG D Ross
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J J WeisD T Fearon
Aug 1, 1993·European Journal of Immunology·P BjörckS Paulie
Apr 1, 1993·European Journal of Immunology·J Y BonnefoyJ Gordon
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·H MolinaD D Chaplin
Apr 1, 1996·The Journal of Experimental Medicine·D A CroixM C Carroll
Jan 6, 1997·The Journal of Experimental Medicine·Y J LiuK W Moore

❮ Previous
Next ❯

Citations

Jul 17, 1999·Immunopharmacology·V Frémeaux-BacchiE M Fischer
Dec 30, 1999·Veterinary Immunology and Immunopathology·A J YoungW R Hein
Jun 11, 1999·Clinical and Experimental Immunology·W J JabsH Klüter
Nov 4, 2004·British Journal of Haematology·Masaki OtsukaSigeru Fujita
Aug 23, 2006·Autoimmunity·Andrea IsaákAnna Erdei
Apr 20, 2001·International Immunology·J Schwab, H Illges
Apr 11, 2008·Clinical and Vaccine Immunology : CVI·Dong LiuZhong-Xiang Niu
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emily C WhippleMargaret A Lindorfer
Sep 20, 2012·Developmental and Comparative Immunology·Eric S PringlePatricia E Shewen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.